CS 2100

913827-99-3

CAS-Nr.: 913827-99-3

Englisch Name:: CS 2100

Synonyma:: CS 2100;1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1;4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid;1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid;3-Azetidinecarboxylic acid, 1-[[4-ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-;CS-2100 1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]- 2-thienyl]methyl]-3-azetidinecarboxylic acid;inhibit,LPL Receptor,CS2100,Inhibitor,CS 2100,immunosuppressive efficacy,HvGR,CS-2100,Lysophospholipid Receptor,S1P3-sparing

CBNumber:: CB43037203

Summenformel:: C25H23N3O4S

Molgewicht:: 461.53

MOL-Datei:: 913827-99-3.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 32

CS 2100 Eigenschaften

Siedepunkt:: 648.0±65.0 °C(Predicted)

Dichte: 1.336±0.06 g/cm3(Predicted)

storage temp.: Store at -20°C

Löslichkeit: <2.31mg/ml in DMSO

pka: 2.63±0.20(Predicted)

InChI: InChI=1S/C25H23N3O4S/c1-2-16-12-21(15-28-13-18(14-28)25(29)30)33-22(16)23-26-24(32-27-23)17-8-10-20(11-9-17)31-19-6-4-3-5-7-19/h3-12,18H,2,13-15H2,1H3,(H,29,30)

InChIKey: DWVJASHDNJMDNH-UHFFFAOYSA-N

SMILES: N1(CC2SC(C3N=C(C4=CC=C(OC5=CC=CC=C5)C=C4)ON=3)=C(CC)C=2)CC(C(O)=O)C1

Sicherheit

CS 2100 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

CS 2100 is a sphingosine-1-phosphate receptor 1 (S1P1) agonist (EC50 = 4.0 nM). Exhibits 5000-fold selectivity for human S1P1 over S1P3. Displays efficacy in a rat adjuvant-induced arthritis model.

CS 2100 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CS 2100 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 32)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd	+86-18341751992 +86-15382112998	757984502@qq.com	China	892	58
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	19892	58
Wuhan Topule Biopharmaceutical Co., Ltd	+8618327326525	masar@topule.com	China	8474	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	52927	58
Wuhan Jingkang en Biomedical Technology Co., Ltd	+8613720134139	orders@jknbiochem.com	China	4691	58
EMMX Biotechnology LLC	888-539-0666	info@emmx.com	United States	8449	60
Shanghai EFE Biological Technology Co., Ltd.	021-65675885 18964387627	info@efebio.com	China	9709	58
Shanghai Rechem science Co., Ltd.	21-31433387 15618786686	sales@rechemscience.com	China	2986	58
Shanghai Han-Xiang Chemical Co., Ltd.	15971444841	amber@biochempartner.com	China	3063	58
BOC Sciences	--	info@bocsci.com	USA	0	65

CS 2100
1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid
3-Azetidinecarboxylic acid, 1-[[4-ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-
CS-2100 1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]- 2-thienyl]methyl]-3-azetidinecarboxylic acid
1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1
4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid
inhibit,LPL Receptor,CS2100,Inhibitor,CS 2100,immunosuppressive efficacy,HvGR,CS-2100,Lysophospholipid Receptor,S1P3-sparing
913827-99-3